公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2015 | The response, outcome and toxicity of aggressive palliative thoracic radiotherapy for metastatic non-small cell lung cancer patients with controlled extrathoracic diseases | YUN CHIANG ; CHIH-HSIN YANG ; Feng-Ming Hsu ; YU-HSUAN CHEN ; JIN-YUAN SHIH ; ZHONG-ZHE LIN ; KENG-HSUEH LAN ; ANN-LII CHENG ; SUNG-HSIN KUO | PLoS ONE | 9 | 9 | |
2022 | Risk of thromboembolism in non-small-cell lung cancers patients with different oncogenic drivers, including ROS1, ALK, and EGFR mutations | Wang, H-Y; SHANG-GIN WU ; YEN-TING LIN ; CHUNG-YU CHEN ; JIN-YUAN SHIH | ESMO open | 3 | 3 | |
2012 | RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer | TZU-HSIU TSAI ; KANG-YI SU ; SHANG-GIN WU ; YIH-LEONG CHANG ; Luo S.-C.; Jane I.-S.; CHONG-JEN YU ; Yue S.-L.; JIN-YUAN SHIH ; PAN-CHYR YANG | European Respiratory Journal | 42 | 37 | |
2011 | The role of epidermal growth factor receptor mutations and epidermal growth factor receptor-tyrosine kinase inhibitors in the treatment of lung cancer | Chang S.-C.; Chang C.-Y.; JIN-YUAN SHIH | Cancers | 5 | 0 | |
2016 | The role of PIK3CA mutations among lung adenocarcinoma patients with primary and acquired resistance to EGFR tyrosine kinase inhibition | SHANG-GIN WU ; YIH-LEONG CHANG ; CHONG-JEN YU ; PAN-CHYR YANG ; JIN-YUAN SHIH | Scientific Reports | 32 | 28 | |
2003 | Roles of Fhit and p53 in Taiwanese surgically treated non-small-cell lung cancers | YIH-LEONG CHANG ; CHEN-TU WU ; JIN-YUAN SHIH ; Lee Y.-C. | British Journal of Cancer | 11 | 10 | |
2010 | Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer | Wu J.-Y.; JIN-YUAN SHIH ; CHIH-HSIN YANG ; KUAN-YU CHEN ; CHAO-CHI HO ; CHONG-JEN YU ; PAN-CHYR YANG | International Journal of Cancer | 53 | 45 | |
2021 | Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC | BIN-CHI LIAO ; Hsu, Wei-Hsun; JIH-HSIANG LEE ; CHING-YAO YANG ; TZU-HSIU TSAI ; WEI-YU LIAO ; CHAO-CHI HO ; CHIA-CHI LIN ; JIN-YUAN SHIH ; CHONG-JEN YU ; Soo, Ross A; CHIH-HSIN YANG | JTO clinical and research reports | 2 | 0 | |
2005 | Sialyl Lewis antigens: Association with MUC5AC protein and correlation with post-operative recurrence of non-small cell lung cancer | CHONG-JEN YU ; JIN-YUAN SHIH ; Lee Y.-C.; CHIA-TUNG SHUN ; ANG YUAN ; PAN-CHYR YANG | Lung Cancer | 47 | 45 | |
2005 | The significance of estrogen receptor β in 301 surgically treated non-small cell lung cancers | CHEN-TU WU ; YIH-LEONG CHANG ; JIN-YUAN SHIH ; Lee Y.-C. | Journal of Thoracic and Cardiovascular Surgery | 162 | 143 | |
2012 | The significance of visceral pleural surface invasion in 321 cases of non-small cell lung cancers with pleural retraction | YIH-LEONG CHANG ; MONG-WEI LIN ; JIN-YUAN SHIH ; CHEN-TU WU ; Lee Y.-C. | Annals of Surgical Oncology | 26 | 20 | |
2017 | Significant clinical factors associated with long-term mortality in critical cancer patients requiring prolonged mechanical ventilation | LI-TA KENG ; KUEI-PIN CHUNG ; SHU-YUNG LIN ; SHENG-KAI LIANG ; Cheng J.-C.; I-CHUN CHEN ; YEN-FU CHEN ; Chang H.-T.; CHIA-LIN HSU ; JIH-SHUIN JERNG ; HAO-CHIEN WANG ; PING-HUNG KUO ; HUEY-DONG WU ; JIN-YUAN SHIH ; CHONG-JEN YU | Scientific Reports | 7 | 7 | |
2011 | Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor | Chang T.-H.; Tsai M.-F.; KANG-YI SU ; SHANG-GIN WU ; Huang C.-P.; SUNG-LIANG YU ; Yu Y.-L.; Lan C.-C.; CHIH-HSIN YANG ; Lin S.-B.; Wu C.-P.; JIN-YUAN SHIH ; PAN-CHYR YANG | American Journal of Respiratory and Critical Care Medicine | 144 | 140 | |
2002 | Small-cell lung cancer presenting with Lambert-Eaton myasthenic syndrome and respiratory failure | Jiang J.-R.; JIN-YUAN SHIH ; HAO-CHIEN WANG ; RUEY-MEEI WU ; CHONG-JEN YU ; PAN-CHYR YANG | Journal of the Formosan Medical Association | 8 | 6 | |
1997 | Sonographic imaging of the trachea | JIN-YUAN SHIH ; LI-NA LEE ; Wu H.-D.; CHONG-JEN YU ; HAO-CHIEN WANG ; YIH-LEONG CHANG ; PAN-CHYR YANG | Journal of Ultrasound in Medicine | 22 | 19 | |
2008 | Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy | CHIH-HSIN YANG ; CHONG-JEN YU ; JIN-YUAN SHIH ; YEUN-CHUNG CHANG ; Hu F.-C.; Tsai M.-C.; KUAN-YU CHEN ; ZHONG-ZHE LIN ; Huang C.-J.; CHIA-TUNG SHUN ; Huang C.-L.; Bean J.; ANN-LII CHENG ; Pao W.; PAN-CHYR YANG | Journal of Clinical Oncology | 240 | 224 | |
2023 | Stage Shift Improves Lung Cancer Survival: Real-World Evidence | CHING-YAO YANG ; YEN-TING LIN ; Lin, Li Ju; Chang, Ya Hsuan; Chen, Hsuan Yu; Wang, Yi Pin; JIN-YUAN SHIH ; CHONG-JEN YU ; PAN-CHYR YANG | Journal of Thoracic Oncology | 9 | 8 | |
2021 | Subsequent Antituberculous Treatment May Not Be Mandatory Among Surgically Resected Culture-Negative Pulmonary Granulomas: A Retrospective Nationwide Multicenter Cohort Study | Chung, Che-Liang; Huang, Wei-Chang; Huang, Hung-Ling; Chin, Chun-Shih; Cheng, Meng-Hsuan; MENG-RUI LEE ; Lin, Sheng-Hao; JANN-YUAN WANG ; Lin, Ching-Hsiung; Chong, Inn-Wen; JIN-YUAN SHIH ; CHONG-JEN YU | Open forum infectious diseases | 2 | 1 | |
2020 | Successful management of a ROS1-rearranged pulmonary pleomorphic carcinoma using serial tyrosine kinase inhibitors | Wu C.-W.; CHING-YAO YANG ; YIH-LEONG CHANG ; JIN-YUAN SHIH | OncoTargets and Therapy | 1 | 1 | |
2013 | Survival of lung adenocarcinoma patients with malignant pleural effusion | SHANG-GIN WU ; CHONG-JEN YU ; Tsai M.-F.; WEI-YU LIAO ; CHIH-HSIN YANG ; I-SHIOW JAN ; PAN-CHYR YANG ; JIN-YUAN SHIH | European Respiratory Journal | 86 | 77 | |